Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice

被引:16
作者
Schild, Andreas
Isenmann, Stefan
Tanimoto, Naoyuki
Tonagel, Felix
Seeliger, Mathias W.
Ittner, Lars M.
Kretz, Alexandra
Ogris, Egon
Goetz, Juergen
机构
[1] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Med Fdn, Sydney, NSW 2006, Australia
[3] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria
[4] Orthoped Univ Hosp Balgrist, Res Lab Calcium Metab, CH-8008 Zurich, Switzerland
[5] Univ Tubingen, Dept Pathophysiol Vis & Neuroophthlamol, Retinal Diagnost Res Grp, D-72076 Tubingen, Germany
[6] Univ Jena, Sch Med, Dept Neurol, D-07747 Jena, Germany
[7] Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland
基金
奥地利科学基金会;
关键词
cadherin; cell adhesion; development; enophthalmos; Ganzfeld electroretinography (ERG); Harderian gland; protein phosphatase 2A (PP2A); scanning laser ophthalmoscopy; transgenic mice;
D O I
10.1016/j.mod.2006.03.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although Harderian glands are especially large in rodents, many features of this retroocular gland, including its development and function, are not well established. Protein phosphatase 2A (PP2A) is a family of heterotrimeric enzymes expressed in this gland. PP2A substrate specificity is determined by regulatory subunits with leucine 309 of the catalytic subunit playing a crucial role in the recruitment of regulatory subunits into the complex in vitro. Here we expressed an L309A mutant catalytic subunit in Harderian gland of transgenic mice. We found a delayed postnatal development and hypoplasia of the gland, causing enophthalmos. To determine why expression of the L309A mutant caused (his phenotype, we determined the PP2A subunit composition. We found an altered subunit composition in the transgenic gland that was accompanied by pronounced changes of proteins regulating cell adhesion. Specifically, cadherin and beta-catenin were dramatically reduced and shifted to the cytosol. Furthermore, we found an inactivating phosphorylation of the cadherin-directed glycogen synthase kinase-3 beta. In conclusion, the carboxy-terminal leucine L309 of the PP2A catalytic subunit determines PP2A heterotrimer composition in vivo. Moreover, our data demonstrate that PP2A subunit composition plays a crucial role in regulating cell adhesion and as a consequence in the development of the Harderian gland. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:362 / 371
页数:10
相关论文
共 61 条
[1]   Effect of okadaic acid and calyculin-A,: Two protein phosphatase inhibitors, on thyrotropin-stimulated triiodothyronine secretion in cultured sheep thyroid cells [J].
Arufe, MC ;
Beckett, GJ ;
Durán, R ;
Alfonso, M .
ENDOCRINE, 1999, 11 (03) :235-240
[2]   Autoregulation of protein phosphatase type 2A expression [J].
Baharians, Z ;
Schönthal, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :19019-19024
[3]   Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Bα subunit [J].
Bryant, JC ;
Westphal, RS ;
Wadzinski, BE .
BIOCHEMICAL JOURNAL, 1999, 339 :241-246
[4]  
Buzzell GR, 1996, MICROSC RES TECHNIQ, V34, P2, DOI 10.1002/(SICI)1097-0029(19960501)34:1<2::AID-JEMT2>3.0.CO
[5]  
2-W
[6]   Characterization of transgene expression and Cre recombinase activity in a panel of Thy-1 promoter-Cre transgenic mice [J].
Campsall, KD ;
Mazerolle, CJ ;
De Repentingy, Y ;
Kothary, R ;
Wallace, VA .
DEVELOPMENTAL DYNAMICS, 2002, 224 (02) :135-143
[7]   Posttranslational modifications of tau -: Role in human tauopathies and modeling in transgenic animals [J].
Chen, F ;
David, D ;
Ferrari, A ;
Götz, J .
CURRENT DRUG TARGETS, 2004, 5 (06) :503-515
[8]  
CotoMontes A, 1997, MICROSC RES TECHNIQ, V38, P311, DOI 10.1002/(SICI)1097-0029(19970801)38:3<311::AID-JEMT11>3.0.CO
[9]  
2-Q
[10]   Functional expression of human PP2Ac in yeast permits the identification of novel C-terminal and dominant-negative mutant forms [J].
Evans, DRH ;
Myles, T ;
Hofsteenge, J ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :24038-24046